Saturday, May 28, 2016 8:19:26 PM
I was responding to a post that began with the phrase "Based on information from contacts with knowledge of NNVC". Turns out that the information was just the opinion of a third party, something that I wouldn't normally consider "information".
Maybe some astute analyst noted exactly what you unearthed:
"As noted by NNVC in the Jan 2016 Biotech Showcase concerning the lead Herpescide candidate:
May - July: Univ testing to select optimum candidate complete
August - Sept: TOX prep complete
Nov - Dec: TOX package complete
Dec - Feb: Human trials begin"
If that astute analyst's "knowledge of NNVC" included the fact that they had a tendency to publish schedules which tended to run late (if ever) I could absolutely picture them telling, or leading a willing listener to believe, that the probability of a price-moving favorable announcement within the next 3 months is less than 10% and within six months less than 25%. That would make sense and not really require that much astutitude.
OR said analyst could have had another basis altogether for their opinion. But the point is that it appears that the "information from contacts with knowledge of NNVC" was simply someone's opinion. I think you had a word for it.
"Successful commercialization is succeeding in the process of
commercializing. It is not successfully having commercialized."
Say what?
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM